The Document Management System for the Pharmaceutical Industry.

Document control that holds up when the inspector walks in.

 

KOŚA DMS is the document management system for pharmaceutical industry teams that routes every SOP, batch record, and validation document through one configurable workflow -version-controlled, e-signed, and audit-trailed for 21 CFR Part 11, EU GMP Annex 11, and ISO 13485.

Trusted by quality & document control teams in pharma, biotech & medical devices

PharmaCorp

BioGenex

MediLabs

CuraVita

NovaPharm

BioTrust

What you can achieve

Built by life science experts to simplify document control.

One controlled system replaces the shared drives, email threads and binders that quality teams stitch together by hand.

Automated & traceable

Centralise document control and replace manual routing with configurable workflows. Reduce manual coordination across teams.

Confident compliance

Designed to support FDA 21 CFR Part 11, EU GMP Annex 11 and ISO 13485 – keeping documentation inspection-ready at all times.

Data-driven oversight

Monitor document activity, review backlogs and compliance KPIs in real time. Give QA leadership the visibility they need.

Faster implementation

Go live in 6–8 weeks with structured implementation, training and 24/7 support – without disrupting existing operations.

HOW DIFFERENT ROLES BENEFIT

One QMS. Every team is aligned.

Built around the processes regulators actually inspect.

HOW QUALITY ASSURANCE USES DMS IN PRACTICE

Regulatory submissions, fully traceable.

HOW REGULATORY AFFAIRS USES DMS IN PRACTICE

Research documentation, kept airtight.

HOW R&D USES DMS IN PRACTICE

Shop-floor documents, always current.

HOW MANUFACTURING & OPS USES DMS IN PRACTICE

Full visibility, at a glance.

HOW MANAGEMENT USES DMS IN PRACTICE

Why a centralized DMS matters

The case for one controlled system, not six workarounds.

Electronic document management system for the pharmaceutical industry is critical to compliance, quality, and safety. Companies that meticulously organise and control their documents mitigate risk and maintain the highest quality standards across drug development and production.

Compliance

Regulatory compliance, by default

Good Documentation Practice (GMP) and GCP expectations are enforced inside the workflow itself – not reconciled afterwards at audit time.

Integrity

Data integrity you can stand behind

Every field, edit and signature is captured under ALCOA++ principles, so the record holds up on its own in front of an inspector.

Traceability

One immutable trail, start to finish

A single audit trail follows each pharma document management from the first draft through every review, approval, re-issue, and retirement.

Risk

Risk surfaced early, not at inspection

Configuration drift, overdue reviews and unassessed changes are flagged while they’re still cheap to fix.

Collaboration

One controlled curriculum, every team

QA, regulatory, manufacturing and lab staff work from the same effective version in real time, wherever they sit.

Access

A centralised repository

Replaces the shared drives, email threads and binders that document control teams currently stitch together by hand.

What a pharma DMS controls

Built for the documents regulators actually ask for.

From raw-material receipt to product release, every step of the pharmaceutical document management system produces a controlled document. KOŚA pharmaceutical document management software is built around the records that matter most during an inspection.

Batch & Manufacturing Records

Raw materials through release testing

Standard Operating Procedures

Lab, cleaning and equipment SOPs

Clinical Trial Protocols & Reports

GCP design, methodology and results

Regulatory Submissions

NDA / MAA dossiers & correspondence

Quality Control Records

Raw material, intermediate and final QC

Validation & Qualification Docs

URS, IQ / OQ / PQ

Change Control & CAPA

Impact assessment and sign-off

Periodic Quality Reviews

PQR and stability data

Reporting & Analytics

Real-time visibility into every document.

Live dashboards expose completion rates and compliance metrics – exports produce audit-ready documentation for every review.

Capabilities

Everything you need to run a controlled document system.

Capability pillars that come standard – no add-ons, no surprises.

Automated workflows

Draft, review, approval and effective-stage routing.

Electronic signatures

Traceable approvals aligned to 21 CFR Part 11.

AI-powered summaries

Automatic change summaries for faster review.

Version control & history

The latest approved document with full traceability.

Role-based access control

Control access by role, site or project.

Properties & classification

Classify by type, process, owner and effective date.

Microsoft Office integration

Draft in Word while control stays inside KOŚA.

Search, filtering & navigation

Full-text search and document properties.

Training records management

Link documents to training assignments.

ERP & LIMS integration

One consistent record across systems.

Reporting & analytics

Track metrics, backlogs and compliance status.

Secure collaboration

Work simultaneously without losing version control.

Regulatory frameworks

Built as the electronic DMS for pharmaceutical industry teams - not a paper-trail patch.

KOŚA document management system for the pharmaceutical industry helps you implement document control processes that maintain traceability, controlled access, and documented oversight across the entire document lifecycle.

21 CFR Part 11

Electronic Records & Signatures

Audit trails, access control & signature binding.

21 CFR Part 211

cGMP Documentation

Including §211.22 quality-unit procedures.
21 CFR Part 820

Quality System Regulation

Medical device design & document history records.

EU GMP Annex 11

Computerised Systems

GMP-regulated manufacturing and quality activities.

ISO 13485:2016

Medical Device QMS

Documentation, including technical file control.

ISO/IEC 27001:2022

Information Security

Management for document repositories and access.

EU MDR / IVDR

Device Documentation

Technical file and post-market requirements.

ICH Q9 · Q10

Quality Risk & Systems

Risk management and pharmaceutical quality systems.

ALCOA++

Data Integrity Principles

Attributable, legible, contemporaneous, original, accurate.

WHO Guidance

Data Integrity

Good documentation practice and data governance.

GAMP 5

Validation

Risk-based validation, including IQ / OQ / PQ.

ISO 14971:2019

Risk Management

Documentation for medical devices.

Implementation

Go live in 6–8 weeks, without disrupting current operations.

A phased, low-risk rollout designed around your validation package and audit calendar with 24/7 support from the first day.

Week 1–2

Discovery & migration plan

Document inventory, gap assessment and a structured cutover plan.

Week 3–4

Configuration & workflow build

Workflows, roles, templates and e-signature rules are configured to your SOPs.

Week 5-6

Validation & UAT

User acceptance testing alongside your validation package, ready for sign-off.

Week 7-8

Go-live & training

Phased go-live with role-based training and 24/7 support from day one.

“Our document control team works much more effectively since we implemented KOŚA pharmaceutical document management software. The workflows are intuitive and our audits have never been smoother.”

Quality Affairs Lead · Mid-market Pharma Manufacturer

Get started

See KOŚA DMS in your environment.

Book a 30-minute walkthrough with a compliance architect – tailored to your SOPs, your workflows and your audit calendar.

21 CFR Part 11 · EU Annex 11 · ALCOA++ · GAMP 5

FAQs

Frequently asked questions

How does an electronic document management system support 21 CFR Part 11 compliance?

 An electronic document management system built for 21 CFR Part 11 binds e-signatures to specific users and actions, timestamps every change in an immutable audit trail, and restricts access by role, so signature integrity and record traceability are enforced by the system itself rather than a manual SOP someone has to remember to follow.

 Yes. KOŚA’s document management system for pharmaceutical industry teams integrates with ERP and LMS so that a document, a batch record, a spec, and a COA stay consistent as a single record across systems, instead of separate, possibly conflicting copies living in each platform.
GxP document control spans SOPs, batch and manufacturing records, validation and qualification documents (URS, IQ/OQ/PQ), clinical trial protocols, regulatory submissions, QC records, change control, CAPA, and periodic quality reviews – essentially any document a regulator could ask to trace from draft to current effective version.
 Most pharmaceutical DMS implementations, including KOŚA’s, go live in 6–8 weeks through a phased rollout: discovery and migration planning; workflow configuration and validation/UAT alongside your CSV package; and a phased go-live with role-based training, designed so document control continues running during the transition rather than pausing for cutover.